We have published revised versions of the OMRON Privacy Policy and Cookie Policy. Your use of our products and services is subject to these revised terms.

This website uses cookies. By continuing to browse through this website, you agree to our Cookie Policy which has been revised in May 2018.

Allow cookies

News Releases & Events

Why prevention matters on World Diabetes Day

 

The number of people diagnosed worldwide with Diabetes is a cause for concern.

The number of people diagnosed worldwide with Diabetes should remain as a cause for serious concern within the medical community, since high fasting plasma glucose (parameter of diabetes) has risen from the 8th. to the 5th. position as a global risk factor DALY (a measure that quantifies lost years of "healthy" life) between 2000 and 2013. At the same time, a new study has recently shown that many independent drivers of health were forecasted to worsen, because of the prevalence of many non-communicable diseases, with diabetes-related morbidity and mortality playing a relevant role amongst them.

Following this issue with mounting concern, at OMRON we are drawing the public’s attention to the need to accurately measure blood pressure in diabetic patients -given the high correlation between diabetes and high blood pressure- in order to step up prevention and effective treatment of hypertension, a related medical condition to diabetes.

 

A significant percentage of diabetic people are also suffering from high blood pressure.

According to the Global Report on Diabetes published by World Health Organization in 2016, an estimated 422 million adults were living with diabetes in 2014. This represents an astonishing increase of 390.7% compared to 1980. In addition, a study conducted by Oxford University shows that people with high blood pressure have up to a 58% greater risk of developing diabetes. Hypertension can be present before diabetes has been diagnosed (Cho N.H. et. Al., 2015) and if and individual has diabetes, the risk of developing hypertension is higher for him than it is for a healthy person. Moreover, hypertension is a great risk factor for accelerating the progression of diabetes (Parati et. Al., 2011).

It is evident that bringing to life technological breakthroughs to accurately measure blood pressure among the diabetic population at home is a societal need. For this reason, OMRON has clinically validated the OMRON M7 Intelli IT for use in diabetic patients.

 

Is there a specific demographic of person (male, female, young, old) at the greatest risk of accelerating their diabetic condition?

In principle, according to WHO, the majority of cases of Diabetes Type 1 occurs in children and adolescents and type 2 Diabetes “is determined by an interplay of genetic and metabolic factors.” An unhealthy diet, family history of diabetes, physical inactivity, obesity, smoking, older age – these are all factors that have been attributed to causing the rise in global diabetes. At the same time, since type 2 Diabetes mostly affects adults and now people tend to live longer, there’s a strong association between diabetes and aging.

Obesity is a peculiar condition. It is highly correlated with diabetes and therefore, with high blood pressure. At the same time, obesity is a great risk factor for hypertension, accounting for 65-75% of the risk for essential hypertension (Marion R., 2004). For this reason, OMRON has also developed the OMRON RS7 Intelli IT, OMRON’s first automatic wrist blood pressure monitor clinically validated for use in obese population. In support of these results, the use of wrist devices to accurately measure blood pressure in obese patients is being recommended.

 

The risks of leaving high blood pressure untreated in diabetics.

By and large, leaving high blood pressure untreated poses great peril for anyone suffering from this condition. According to WHO, if left uncontrolled, hypertension can lead to heart attack, an enlargement of the heart and eventually heart failure. For these reasons, according to the International Society of Hypertension, high blood pressure is the No. 1 contributing risk factor for global death and 10 million people die unnecessarily every year due to raised blood pressure.

When taking diabetics into account, the risk for a cardiovascular event such as stroke is 2 to 4 times higher in people with diabetes than it is in healthy people (Deshpande AD et. Al., 2008).

 

Measures of control can have a positive effect on the health of diabetic people.

Taking into account the relationship between hypertension and diabetes that was shown along these lines, we can conclude that tight blood pressure control policy can reduce the risk associated to diabetes. For this reason, getting ensured accuracy when taking their measurements is key to enhance prevention and control amongst the diabetics.

Committed to help people minimize the impact of this condition to live better, longer and more actives lives, OMRON has clinically validated the OMRON M7 Intelli IT home blood pressure monitor for use in diabetic patients. Higher levels of glucose in the bloodstream lead to hardening of the arteries and in turn, to difficulties in the appropriate measurement of blood pressure. Since these particular conditions might render blood pressure readings inaccurate, diabetics need to be sure they are choosing devices clinically-validated for use in diabetic population, which guarantee the same level of accuracy they would get at their Doctor’s office.

On a global scale and quoting a recent study on the evolution of life expectancy, “policy choices can profoundly affect future health trajectories. Prioritizing non-communicable diseases (NCDs) [such us high blood pressure and diabetes] and NCD-related risks in health planning and investment decisions has the potential to markedly reduce premature mortality by 2040”.

 

Our goal in fighting the risks of diabetes.

OMRON is committed to help people minimize the impact of health conditions to help them live better, longer and more active lives, making zero compromises on health. With this vision charting the course of our actions, we are going further than just getting our blood pressure monitors clinically validated in the general population. We understand that specific groups such as the obese, pregnant women and diabetic patients have particular needs, which we address with specialized clinical validations that provide them a greater deal of reassurance when using our devices. The results from the clinical validation in obese people, diabetic patients and pregnant women have strongly confirmed our beliefs and we are proud to offer more and more professionalized devices over time.